(Q38025104)

27 August 2017

0 references

ACS chemical neuroscience spotlight on CEP-1347 (English)

1 reference

27 August 2017

1 reference

Zachary K Sweeney

1

1 reference

PMC publication ID

3369704

27 August 2017

Joseph W Lewcock

series ordinal

2

1 reference

27 August 2017

3 September 2010

1 reference

ACS Chemical Neuroscience

27 August 2017

1 reference

27 August 2017

2

1 reference

27 August 2017

1

1 reference

27 August 2017

3-4

1 reference

Genetic animal models of Parkinson's disease

27 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369704

JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369704

Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseases.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369704

Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369704

Inhibition of the c-Jun N-terminal kinase signaling pathway by the mixed lineage kinase inhibitor CEP-1347 (KT7515) preserves metabolism and growth of trophic factor-deprived neurons.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369704

Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369704

CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3369704

The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22778853

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/CN1000793

1 reference

27 August 2017

1 reference

PMC publication ID

3369704

27 August 2017

PubMed publication ID

22778853

1 reference

PMC publication ID

3369704